Measuring Quality of Life in Ovarian Cancer Clinical Trials—Can We Improve Objectivity and Cross Trial Comparisons?

SIMPLE SUMMARY: Regarded as the “disease that whispers” ovarian cancer remains difficult to diagnose and treat due to other complex conditions that may occur together. As research into new treatments for ovarian cancer continues, growing efforts to understand how treatments may be impact the day to...

Descripción completa

Detalles Bibliográficos
Autores principales: Bhat, Gita, Karakasis, Katherine, Oza, Amit M.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2020
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7694966/
https://www.ncbi.nlm.nih.gov/pubmed/33171791
http://dx.doi.org/10.3390/cancers12113296

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7694966/
https://www.ncbi.nlm.nih.gov/pubmed/33171791
http://dx.doi.org/10.3390/cancers12113296

Ejemplares similares